Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screen

6 Oct 2020

Abstract excerpt

Almost all currently approved systemic therapies for hepatocellular carcinoma (HCC) failed to achieve satisfactory therapeutic effect. Exploring tailored treatment strategies for different individuals provides an approach with the potential to maximize clinical benefit. Previously, multiple studies have reported that hepatoma cell lines belonging to different molecular subtypes respond differently to the same...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33167027
DOI: 10.1093/bib/bbaa295

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring subclass-specific therapeutic agents for hepatocellular carcinoma by informatics-guided drug screenPMID 33167027Read ↗

In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessmentSemantic proximity Read ↗

Integrated analysis of hepatocellular carcinoma reveals disparate subtype of prognosis significanceSemantic proximity Read ↗

Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneitySemantic proximity Read ↗

Dimensions of hepatocellular carcinoma phenotypic diversitySemantic proximity Read ↗

Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular CarcinomaSemantic proximity Read ↗

Molecular classification of hepatocellular carcinoma: potential therapeutic implicationsSemantic proximity Read ↗

Integrated transcriptomic analyses identifies host-targeting repurposing drugs for hepatitis C virus infection and related hepatocellular carcinomaSemantic proximity Read ↗

Deciphering the Oncogenic Landscape of Hepatocytes Through Integrated Single‐Nucleus and Bulk RNA‐Seq of Hepatocellular CarcinomaSemantic proximity Read ↗

Subtype and pathway specific responses to anticancer compounds in breast cancerSemantic proximity Read ↗

Case Study of Single-cell Protein Activity Based Drug Prediction for Precision Treatment of CholangiocarcinomaSemantic proximity Read ↗

Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactionsSemantic proximity Read ↗

Single-Cell RNA Sequencing, Cell Communication, and Network Pharmacology Reveal the Potential Mechanism of Senecio scandens Buch.-Ham in Hepatocellular Carcinoma InhibitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.